Mohsen Nikseresht
Mohsen Nikseresht is an expert in Biochemistry at Yasuj University of Medical Sciences (Iran). Mohsen Nikseresht has authored 35 publications, the most recent in 2025. SLR score: 81 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1995 - 2025
Number : 35
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Mitigating Heat-Induced Sperm Damage and Testicular Tissue Abnormalities: The Protective Role of Radiofrequency Radiation from Wi-Fi Routers in Rodent Models. PMID 41377131 — cells, stress, physiological, tissues, spermatozoa, heat stress disorders, testis | J Biomed Phys Eng | 2025 | 2 |
| Nanocodelivery of 5-Fluorouracil and Curcumin by RGD-Decorated Nanoliposomes Achieves Synergistic Chemotherapy for Breast Cancer. PMID 39629226 — cells, breast neoplasms, pharmaceutical preparations, liposomes, antineoplastic agents, neoplasms, drug therapy, fluorouracil, breast, curcumin, therapeutics, apoptosis, nanotechnology, lip, chemotherapy | IET Nanobiotechnol | 2024 | 0 |
| Targeting PERK and GRP78 in colorectal cancer: Genetic insights and novel therapeutic approaches. PMID 39153651 — genes, neoplasms, pharmacology, diagnosis, therapeutics, colorectal neoplasms, tissues, unfolded protein response | Eur J Pharmacol | 2024 | 1 |
| Multi-Drug Resistance against Second-Line Medication and MicroRNA Plasma Level in Metastatic Breast Cancer Patients. PMID 36895459 — plasma, pharmaceutical preparations, drug resistance, multiple, breast neoplasms, case-control studies, micrornas, real-time polymerase chain reaction, multiple chronic conditions, chemotherapy | Iran J Med Sci | 2023 | 1 |
| Circulating mRNA and plasma levels of osteoprotegerin and receptor activator of NF-κB ligand in nonalcoholic fatty liver disease. PMID 33010062 — liver diseases, cytokines, genes, osteoprotegerin, biochemistry, non-alcoholic fatty liver disease, genetic techniques, rna, messenger, liver, microbiological techniques, fatty liver, ligands, plasma, gene expression | Biotechnol Appl Biochem | 2020 | 8 |
LeadR Networks
Main global connection map